Completeness of RET testing in patients with medullary thyroid carcinoma in Denmark 1997-2013: a nationwide study
The completeness of arranged during ransfection ( ) testing in patients with medullary thyroid carcinoma (MTC) was recently reported as 60%. However, the completeness on a population level is unknown. Similarly, it is unknown if the first Danish guidelines from 2002, recommending testing in all MTC...
Gespeichert in:
Veröffentlicht in: | Clinical epidemiology 2019-01, Vol.11, p.93-99 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The completeness of
arranged during
ransfection (
) testing in patients with medullary thyroid carcinoma (MTC) was recently reported as 60%. However, the completeness on a population level is unknown. Similarly, it is unknown if the first Danish guidelines from 2002, recommending
testing in all MTC patients, improved completeness in Denmark. We conducted a nationwide retrospective cohort study aiming to evaluate the completeness of
testing in the Danish MTC cohort. Additionally, we aimed to assess the completeness before and after publication of the first Danish guidelines and characterize MTC patients who had not been tested.
The study included 200 patients identified from the nationwide Danish MTC cohort 1997-2013. To identify
tested MTC patients before December 31, 2014, the MTC cohort was cross-checked with the nationwide Danish
cohort 1994-2014. To characterize MTC patients who had not been
tested, we reviewed their medical records and compared them with MTC patients who had been tested.
Completeness of
testing in the overall MTC cohort was 87% (95% CI: 0.81-0.91; 173/200). In the adjusted MTC cohort, after excluding patients diagnosed with hereditary MTC by screening, completeness was 83% (95% CI: 0.76-0.88; 131/158). Completeness was 88% (95% CI: 0.75-0.95; 42/48) and 81% (95% CI: 0.72-0.88) (89/110) before and after publication of the first Danish guidelines, respectively. Patients not
tested had a higher median age at diagnosis compared to those
tested. Median time to death was shorter in those not tested relative to those tested.
The completeness of
testing in MTC patients in Denmark seems to be higher than reported in other cohorts. No improvement in completeness was detected after publication of the first Danish guidelines. In addition, data indicate that advanced age and low life expectancy at MTC diagnosis may serve as prognostic indicators to identify patients having a higher likelihood of missing the compulsory
test. |
---|---|
ISSN: | 1179-1349 1179-1349 |
DOI: | 10.2147/CLEP.S183268 |